Live Breaking News & Updates on Cejemly

Stay updated with breaking news from Cejemly. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Sugemalimab Plus Chemo Receives Approval in China for Esophageal Squamous Cell Carcinoma

The National Medical Products Administration of China has approved sugemalimab paired with fluorouracil and platinum-based chemotherapy for use in the frontline treatment of patients with unresectable locally advanced, recurrent, or metastatic esophageal squamous cell carcinoma. ....

Li Jin , Department Of Oncology At East Hospital , Cstone Pharmaceuticals , National Medical Products Administration Of China , Tongji University , National Medical Products Administration , East Hospital , National Medical Products Administration Of China , Fluorouracil And Platinum Based Chemotherapy , Phase 3 Gemstone 304 Study ,

CStone Pharmaceuticals: CSTONE ANNOUNCED NEW DRUG APPROVAL OF CEJEMLY (SUGEMALIMAB) IN CHINA TO POTENTIALLY RESHAPE THE LANDSCAPE OF IMMUNO-ONCOLOGY THERAPY IN LUNG CANCER

SUZHOU, China, Dec. 21, 2021 /PRNewswire/ CStone Pharmaceuticals (the "Company" or "CStone") is pleased to announce that the National Medical Products Administration ("NMPA") of China has ....

Jason Yang , Caicun Zhou , Frank Jiang , U Ligand Corporation , Prnewswire Cstone Pharmaceuticals The Company , Drug Administration , National Medical Products Administration , Shareholders Of The Company , Department Of Oncology , Oncology Trends , Principal Investigator , Shanghai Pulmonary Hospital , Chief Medical Officer , Ligand Corporation , Greater China , Proffered Paper Oral Presentation , Late Breaking Abstract , Mini Oral Presentation , Mainland China , Breakthroughs That Change Patient , Listing Rules ,